Home » Topics » Disease categories and therapies » Infection

Infection
RSS

Potent new antimalarial trioxanes developed at Johns Hopkins

Sep. 2, 1998

Mylan acquires U.S. marketing rights to Zagam

Sep. 1, 1998

RiboGene and EnzyMed to collaborate on antiinfective drug discovery

Sep. 1, 1998

Highly active and stable new carbapenems described by Meiji Seika

Aug. 31, 1998

New cephalosporin derivatives active against MRSA

Aug. 28, 1998

Wakunaga discloses new antibacterial agents in early development

Aug. 28, 1998

Scientists solve 3D structure of enzyme that confers bacterial resistance to gentamicin

Aug. 28, 1998

IMpact-RSV trial results announced at international congress

Aug. 26, 1998

Nymox progresses with development of NX-B4221

Aug. 25, 1998

Strategy to improve the bioavailability of anthelmintic agents

Aug. 24, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 15, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 15, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...